The Acute Myeloid Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals. Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2024 | Racial and ethnic disparities in AML: outcomes for Hispanic patients
Sharlene Dong, MD, UT Southwestern Medical Center, Dallas, TX, speaks on racial and ethnic disparities in acute myeloid leukemia (AML). She discusses a study investigating the prognosis of AML in the Hispanic population, which found that Hispanic ethnicity was associated with improved outcomes. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
